Medical masks vs N95 respirators for preventing COVID-19 in healthcare workers: A systematic review and meta-analysis of randomized trials.
Bartoszko JJ, Farooqi MAM, Alhazzani W, Loeb M. · 2020
Read Medical masks vs N95 respirators for preventing COVID-19 in healthcare workers: A systematic review and meta-analysis of randomized trials. by Bartoszko JJ, Farooqi MAM, Alhazzani W, Loeb M. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7298295.txt.
Introduction
Bartoszko and co-authors ask whether plain medical masks protect health staff as well as N95 respirators. Their review pools the randomized trials on the point. Advice clashed early in the COVID-19 outbreak, and hard proof was thin. The team searched the main medical databases for trials that set the two head to head.
Four trials could be pooled. Staff in plain masks caught no more lab-proven viral chest infections than staff in N95s; the odds ratio was 1.06. For chest illness judged by symptoms, the gap was also unclear. One trial looked at coronaviruses on their own and found no gap at all. The team rates the proof as low to very low in strength, so their close is a soft one: the two may in fact protect about the same.
Catalog record
| CREATOR | Bartoszko JJ, Farooqi MAM, Alhazzani W, Loeb M. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Medical masks vs N95 respirators for preventing COVID‐19 in healthcare workers: A systematic review and meta‐analysis of randomized trials By Jessica J. Bartoszko, Mohammed Abdul Malik Farooqi, Waleed Alhazzani, Mark Loeb Published in: Influenza and Other Respiratory Viruses DOI: 10.1111/irv.12745 ABSTRACT Abstract Background Respiratory protective devices are critical in protecting against infection in healthcare workers at high risk of novel 2019 coronavirus disease (COVID‐19); however, recommendations are conflicting and epidemiological data on their relative effectiveness against COVID‐19 are limited. Purpose To compare medical masks to N95 respirators in preventing laboratory‐confirmed viral infection and respiratory illness including coronavirus specifically in healthcare workers. Data Sources MEDLINE, Embase, and CENTRAL from January 1, 2014, to March 9, 2020. Update of published search conducted from January 1, 1990, to December 9, 2014. Study Selection Randomized controlled trials (RCTs) comparing the protective effect of medical masks to N95 respirators in healthcare workers. Data Extraction Reviewer pair independently screened, extracted data, and assessed risk of bias and the certainty of the evidence. Data Synthesis Four RCTs were meta‐analyzed adjusting for clustering. Compared with N95 respirators; the use of medical masks did not increase laboratory‐confirmed viral (including coronaviruses) respiratory infection (OR 1.06; 95% CI 0.90‐1.25; I 2 = 0%; low certainty in the evidence) or clinical respiratory illness (OR 1.49; 95% CI: 0.98‐2.28; I 2 = 78%; very low certainty in the evidence). Only one trial evaluated coronaviruses separately and found no difference between the two groups (P = .49). Limitations Indirectness and imprecision of available evidence. Conclusions Low certainty evidence suggests that medical masks and N95 respirators offer similar protection against viral respiratory infection including coronavirus in healthcare workers during non–aerosol‐generating care. Preservation of N95 respirators for high‐risk, aerosol‐generating procedures in this pandemic should be considered when in short supply. INTRODUCTION Novel 2019 coronavirus disease (COVID‐19) was declared a pandemic by the World Health Organization (WHO) on March 11, 2020, after the identification of >118 000 cases in 114 countries. 1 As government officials and public health stakeholders implement measures to slow the spread of SARS‐CoV‐2, healthcare workers treating COVID‐19 patients are among those at highest risk of infection. During the severe acute respiratory disease (SARS) pandemic in 2003, healthcare workers made up 21% (1706/8096) of global cases. 2 An early report from a single‐center case series of 138 hospitalized patients for COVID‐19 in Wuhan, China in January 2020 found that 29% (40/138) were healthcare workers that had been infected in hospital. 3 As of February 11, 2020, China's Infectious Disease Information System has reported COVID‐19 in 1716 healthcare workers. 4 Although the transmission of COVID‐19 is not yet fully understood, it is believed to be mainly through large respiratory droplets. 5 For aerosol‐generating procedures, such as intubation or bronchoscopy, there is consensus that N95 respirators offer better protection than medical masks. 6 , 7 , 8 , 9 N95 respirators are designed to minimize facial seal leakage because of tight fit and prevent inhalation of small airborne particles. They also are required to pass filtration tests. In contrast, medical masks (also known as surgical masks) are loose fitting, provide barrier protection against large droplets and prevent hand‐to‐face contact. 10 Globally, current recommendations to protect healthcare workers against COVID‐19 for non–aerosol‐generating care are conflicting. 6 , 7 , 8 , 9 For example, the U.S Centers for Disease Control and Prevention (CDC) and European Centre for Disease and Prevention (ECDC) recommend the N95 respirator for non–aerosol‐generating routine care of patients with COVID‐19, 6 , 7 while the World Health Organization and the Public Health Agency of Canada recommend medical masks. 8 , 9 Shortages of personal protective equipment for healthcare workers, including medical masks and N95 respirators, have been widely reported in this pandemic. 11 A shortage of N95 respirators for aerosol‐generating procedures, where the risk to healthcare workers is high, is of particular concern. This, along with conflicting recommendations, warrants an update of previous systematic reviews (where the last search was conducted in 2015). 12 , 13 Evidence to support similar relative effectiveness of medical masks compared with N95 respirators might help preserve stockpiles of N95 respirators for aerosol‐generating procedures. On the other hand, if N95 respirators are clearly more effective, then their use for non–aerosol‐generating procedures should be universally recommended. We conducted an updated systematic review and meta‐analysis to help answer this question. METHODS We adhered to the PRISMA statement when reporting of this review (Appendix S1). 14 Data sources and searches We adapted search strategies published by Smith et al by removing terms related to surrogate exposure studies (ie, simulations and experiments involving manikins) and applying database‐specific randomized controlled trial (RCT) filters (Appendix S2A‐C). 12 , 15 We searched MEDLINE (OVID interface, Epub Ahead of Print, In‐Process & Other Non‐Indexed Citations, 1946 to Present), Embase (OVID interface, 1974 to Present) and the Cochrane Central Register of Controlled Trials (CENTRAL) from January 1, 2014, to March 9, 2020, for English‐language studies to update their search completed on December 9, 2014. 12 Two reviewers independently and in duplicate screened titles, abstracts and full‐texts of records identified by our searches. Consensus was reached through discussion among the review pair when necessary. Study selection We included RCTs that met all the following criteria: the design was an RCT including cluster randomized trials; the intervention was medical masks (defined surgical, procedural, isolation, laser, fluid resistant or face masks certified for use as a medical device) compared with N95 respirators (defined as respirators were N95 filtering face piece respirators certified by the National Institute for Occupational Safety and Health (NIOSH) and European standard filtering facepiece (FFP2) respirators) 12 ; the population was healthcare workers (defined as workers in a healthcare setting that could be exposed to a patient with acute respiratory illness) and reported on any of the following outcomes: viral respiratory infection laboratory confirmed by PCR, serology, or viral culture (our primary outcome), laboratory‐confirmed coronavirus infection, laboratory‐confirmed influenza infection, influenza‐like illness, clinical respiratory illness, or workplace absenteeism. Data extraction and quality assessment A single reviewer extracted data on study characteristics, participant characteristics, and cases of respiratory illness or infection into a standardized form. A second reviewer completed quality control on the extracted data to ensure its integrity. We combined data from fit tested and non‐fit tested N95 respirator groups for MacIntyre 2011 to generate a single comparator N95 group. 16 Similarly, we combined targeted use of N95 respirators with non‐targeted use of N95 respirators for MacIntrye 2013. 17 For Radonovich 2019, we used healthcare worker‐seasons as the population metric (denominator) given that healthcare workers were treated independently and allowed to participate for up to all 4 years the study was conducted (2011/12 to 2014/15). 18 Reviewers assessed risk of bias of eligible RCTs independently and in duplicate using a modified Cochrane risk of bias tool. 19 Selection bias (random sequence generation and allocation concealment), performance bias (blinding of participants and personnel and other threats to validity), detection bias (blinding of outcome assessment and other potential threats to validity), attrition bias (incomplete outcome data), and reporting bias (selective outcome reporting assessed by comparing outcomes reported in the protocol to those in the published study or by comparing outcomes reported in the results to those in the methods of the